| Title: |
Felzartamab Durably Reduces Disease-Relevant Biomarkers through Targeting of CD38+ Plasma Cells and Plasmablasts, the Upstream Drivers of IgAN ; FR-OR69 |
| Authors: |
Barratt, Jonathan; Shah, Millie; Kivman, Lisa; Kräft, Tabea; Rauser, Julia; Boxhammer, Rainer; Haertle, Stefan; Schwartz, Brian M.; Manser, Paul; Chinn, Leslie; Patel, Uptal D.; Flesher, Donna; Kiryluk, Krzysztof |
| Source: |
Journal of the American Society of Nephrology ; volume 35, issue 10S ; ISSN 1046-6673 1533-3450 |
| Publisher Information: |
Ovid Technologies (Wolters Kluwer Health) |
| Publication Year: |
2024 |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1681/asn.2024ksce36pq |
| DOI: |
10.1681/ASN.2024ksce36pq |
| Availability: |
https://doi.org/10.1681/asn.2024ksce36pq; https://journals.lww.com/10.1681/ASN.2024ksce36pq |
| Accession Number: |
edsbas.A91D2D3A |
| Database: |
BASE |